Large-scale testing (Phase 3)Study completedNCT02260817
What this trial is testing
Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer
Who this might be right for
Metastatic Prostate Cancer
Global Isotopes, LLC d/b/a Zevacor Molecular 109